$1.62
0.074.52%
Pre-Market: 9:27 AM EDT
15 minutes delayed
Plus Therapeutics
PSTVNASDAQ
Plus Therapeutics (PSTV) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPlus Therapeutics (NASDAQ:PSTV) Stock Quotes, Forecast and News Summary
Plus Therapeutics Stock (NASDAQ: PSTV) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 5.00 / 75.86K |
| Day Range | - - - |
| 52 Wk Range | 0.97 - 3.21 |
| Market Cap | $9.24M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 3.6% |
| Days to Cover | 3.05 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Plus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, develo...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Plus Therapeutics (PSTV) stock?
You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.
Who are Plus Therapeutics (PSTV) competitors?
Other companies in Plus Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Addex Therapeutics (NASDAQ:ADXN).
What is the target price for Plus Therapeutics (PSTV) stock?
There is no analysis for Plus Therapeutics.
What is the forecast for Plus Therapeutics (PSTV) stock?
Plus Therapeutics has a consensus price target of $8.33.
Current stock price for Plus Therapeutics (PSTV)?
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $1.62 last updated July 2, 2024 at 9:27 AM EDT.
Does Plus Therapeutics (PSTV) pay a dividend?
There are no upcoming dividends for Plus Therapeutics.
When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?
Plus Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Plus Therapeutics (PSTV) going to split?
There is no upcoming split for Plus Therapeutics.
What sector and industry does Plus Therapeutics (PSTV) operate in?
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.